BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19236775)

  • 1. [Expression of human factor IX in retrovirus-transfected human umbilical cord tissue derived mesenchymal stem cells].
    Chen XL; Dong CL; Feng XM; Chen ZP; Zhou ZP; Xu XH; Zhao QJ; Qiu ZY; Ren Q; Zhang L; Han ZC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):184-7. PubMed ID: 19236775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion.
    Cherington V; Chiang GG; McGrath CA; Gaffney A; Galanopoulos T; Merrill W; Bizinkauskas CB; Hansen M; Sobolewski J; Levine PH; Greenberger JS; Hurwitz DR
    Hum Gene Ther; 1998 Jul; 9(10):1397-407. PubMed ID: 9681411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.
    Sam MR; Azadbakhsh AS; Farokhi F; Rezazadeh K; Sam S; Zomorodipour A; Haddad-Mashadrizeh A; Delirezh N; Mokarizadeh A
    Biologicals; 2016 May; 44(3):170-7. PubMed ID: 26928674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients.
    Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL
    Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Splicing and stability of intron in the expression retroviral vector with human clotting factor IX].
    Xing YN; Lu DR; Gao XB; Qiu XF; Xue JL
    Yi Chuan Xue Bao; 1998 Dec; 25(6):471-7. PubMed ID: 10465892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
    Krebsbach PH; Zhang K; Malik AK; Kurachi K
    J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted introduction and effective expression of hFIX at the AAVS1 locus in mesenchymal stem cells.
    Li SJ; Luo Y; Zhang LM; Yang W; Zhang GG
    Mol Med Rep; 2017 Mar; 15(3):1313-1318. PubMed ID: 28112377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
    Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
    Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human coagulation factor IX gene therapy in murine hemophilia B by hydrodynamic delivery and site-specific genomic integration].
    Zhang L; Gu DS; DU WT; Liu PX; Lu SH; Yang RC
    Zhonghua Xue Ye Xue Za Zhi; 2010 May; 31(5):294-9. PubMed ID: 21122306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system.
    Wahlfors JJ; Morgan RA
    Hum Gene Ther; 1999 May; 10(7):1197-206. PubMed ID: 10340551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B].
    Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB
    Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo.
    Miao CH; Thompson AR; Loeb K; Ye X
    Mol Ther; 2001 Jun; 3(6):947-57. PubMed ID: 11407909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increment of hFIX expression with endogenous intron 1 in vitro.
    Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF
    Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioengineering of differentiated hepatocytes with human factor IX-expressing plasmids in vitro.
    Azadbakhsh AS; Sam MR; Farokhi F
    Bioengineered; 2016 Nov; 7(6):497-503. PubMed ID: 27458870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of Adenovirus-mediated Human Clotting Factor IX Gene in Mouse Adipose-derived Stem Cells].
    Wang X; Wang LH; Xie YY; Li J; Yan ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1718-1725. PubMed ID: 33067980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from hemophilia B patient by retroviral vectors.
    Dai YF; Qiu XF; Xue JL; Liu ZD
    Sci China B; 1992 Feb; 35(2):183-93. PubMed ID: 1581003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained expression of coagulation factor IX by modified cord blood-derived mesenchymal stromal cells.
    Dodd M; Marquez-Curtis L; Janowska-Wieczorek A; Hortelano G
    J Gene Med; 2014; 16(5-6):131-42. PubMed ID: 24947827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic mice can express mutant human coagulation factor IX with higher level of clotting activity.
    Yan JB; Wang S; Huang WY; Xiao YP; Ren ZR; Huang SZ; Zeng YT
    Biochem Genet; 2006 Oct; 44(7-8):349-60. PubMed ID: 17028784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolation and gene modification of amniotic fluid derived progenitor cells].
    Yang C; Fan S; Tang H; Gong Z; Gong X; Ren Z; Zeng F
    Sheng Wu Gong Cheng Xue Bao; 2014 Mar; 30(3):492-503. PubMed ID: 25007585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High expression of human FIX(hFIX) in transgenic mice directed by goat beta-casein gene promoter].
    Huang Z; Yan JB; Huang Y; Sun Q; Xiao YP; Huang Y; Zeng YT
    Yi Chuan Xue Bao; 2002; 29(3):206-11. PubMed ID: 12182072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.